Kramer W G, Gross D R, Medlock C
J Pharm Sci. 1985 May;74(5):569-71. doi: 10.1002/jps.2600740517.
The potential role of the lung in the disposition of meperidine was examined in six conscious dogs instrumented for measurement of appropriate hemodynamic parameters. Following an intravenous bolus injection of 5 mg/kg, blood samples were collected simultaneously from cannulas placed in the left ventricle and the pulmonary artery, concurrent with the hemodynamic measurements. Pulmonary clearance, calculated from concentration differences between pulmonary arterial and left ventricular blood and pulmonary blood flow, averaged 12.1 +/- 3.70 mL/min/kg, accounting for 58 +/- 13% of the total clearance of the drug. These results help resolve differences between previously reported meperidine clearance in the dog and physiological blood flows and imply that the dog may be a poor model for this drug in humans where clearance is primarily hepatic.
在六只植入了用于测量适当血流动力学参数仪器的清醒犬中,研究了肺在哌替啶处置中的潜在作用。静脉推注5mg/kg后,在进行血流动力学测量的同时,从置于左心室和肺动脉的插管中同时采集血样。根据肺动脉血与左心室血之间的浓度差异以及肺血流量计算出的肺清除率平均为12.1±3.70 mL/min/kg,占该药物总清除率的58±13%。这些结果有助于解决先前报道的犬体内哌替啶清除率与生理血流量之间的差异,并表明犬可能不是该药物在人体内的良好模型,因为在人体内清除主要是肝脏清除。